Fulminant hepatic failure following overdose of the vitamin A metabolite acitretin

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 2, 2009, Pages 230-232

  Leithead, Joanna A ^a   Simpson, Ken J ^a   MacGilchrist, Alastair J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Acitretin; Acute liver failure; Adverse effects; Overdose

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; CREATINE KINASE; ETRETIN; GAMMA GLUTAMYLTRANSFERASE; KERATOLYTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE SEVERITY; DRUG OVERDOSE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; KIDNEY DYSFUNCTION; LABORATORY TEST; LIVER FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; PSORIASIS; ACUTE LIVER FAILURE; CHEMICALLY INDUCED; PSYCHOLOGY; SUICIDE ATTEMPT;

ACITRETIN; ADULT; DRUG OVERDOSE; FEMALE; HUMANS; KERATOLYTIC AGENTS; LIVER FAILURE, ACUTE; PSORIASIS; SUICIDE, ATTEMPTED;

EID: 59149093139     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830dffd0     Document Type: Article

References (17)

1. Rodahl K, Moore T. The vitamin A content and toxicity of bear and seal liver. Biochem J 1943; 37:166-168.
2. Biesalski HK. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 1989; 57:117-161.
3. Guebel AP, De Galocsy C, Alves N, Rahier J, Dive C. Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 1991; 100:1701-1709.
4. Cheruvattath R, Orrego M, Gautam M, Byrne T, Alam S, Voltchenok M, et al. Vitamin A toxicity: when one a day doesn't keep the doctor away. Liver Transpl 2006; 12:1888-1891.
5. Miksad R, De Ledinghen V, McDougall C, Fiel I, Rosenberg H. Hepatic hydrothorax associated with vitamin a toxicity. J Cli Gastroenterol 2002; 34:275-279.
6. Anand A, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26:62-68.
7. McClure SL, Valentine J, Gordon KB. Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug Saf 2002; 25:913-927.
8. Glazer SD, Roenigk HH Jr, Yokoo H, Sparberg M, Paravicini U. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate. J Am Acad Dermatol 1984; 10:632-638.
9. Roenigk HH Jr, Callen JP, Guzzo CA, Katz HI, Lowe N, Madison K, et al. Effects of acitretin on the liver. J Am Acad Dermatol 1999; 41:584-588.
10. Van Ditzhuijsen TJ, Van Haelst UJ, Van Dooren-Greebe PJ, Van de Kerkhof PC, Yap SH. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin). J Hepatol 1990; 11:185-188.
11. Weiss VC, Layden T, Spinowitz A, Buys CM, Nemchausky BA, West DP, et al. Chronic active hepatitis associated with etretinate therapy. Br J Dermatol 1985; 112:591-597.
12. Camuto P, Shupack J, Orbuch P, Tobias H, Sidhu G, Feiner H. Long-term effects of etretinate on the liver in psoriasis. Am J Surg Pathol 1987; 11:30-37.
13. Kreiss C, Amin S, Nalesnik MA, Chopra K, Shakil AO. Severe cholestatic hepatitis in a patient taking acitretin. Am J Gastroenterol 2002; 97:775-777.
14. Bray BJ, Rosengren RJ. Retinol potentiates acetaminophen-induced hepatotoxicity in the mouse: mechanistic studies. Toxicol Appl Pharmacol 2001; 173:129-136.
15. Davern TJ, James LP, Hinson JA, Poison J, Larson AM, Fontana RJ, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006; 130:687-694.
16. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139:846-850.
17. Starling J III, Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J Drugs Dermatol 2005; 4:690-696.